Navigation Links
Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
Date:6/30/2008

HOLMDEL, N.J., June 30 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its quality management program.

Genzyme purchased TrackWise to handle Corrective and Preventive Actions (CAPA) as well as deviations and investigations. The TrackWise solution was chosen to replace an existing solution and legacy systems due to its ease of use, extensive reporting capabilities, user interface and industry standard acceptance.

According to Dave Dentino, director, quality and technical operations systems at Genzyme Corporation, "TrackWise has already proven itself through user acceptance and ease of configuration. We have already realized a benefit through the ease with which the system enabled global harmonization of our business processes."

"We are pleased that Genzyme selected Sparta to provide a single, consolidated tool for managing the core elements of their quality management operation," said James E. McGowan, president and CEO, Sparta Systems. "TrackWise has become the industry standard due to its flexibility through configuration, ease of integration and unmatched functionality and we look forward to a future global deployment with Genzyme to all their manufacturing sites."

About Sparta Systems

Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a Web-based enterprise software application used by quality, manufacturing, regulatory affairs and business professionals to manage quality, compliance issues and action items across the enterprise. The company has more than 14 years of experience and an extensive customer base in life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the on-site support required throughout the project lifecycle. More information about Sparta Systems and TrackWise can be found at http://www.sparta-systems.com.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

PR Contacts:

Jon Rabinowitz

Director of Marketing

Sparta Systems, Inc.

Tel: 732-203-0400 x121

jon.rabinowitz@sparta-systems.com


'/>"/>
SOURCE Sparta Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
2. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
3. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
4. Concuity Announces Partnership with Financial Healthcare Systems, LLC
5. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
6. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
7. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
8. Coapt Systems New CEO, Laureen DeBuono, to Fuel Companys Growth and Product Innovation
9. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
10. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
11. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):